Paul Watkins
About Paul Watkins
Paul Watkins serves as the Director of Clinical Operations at MAIA Biotechnology, Inc. He has extensive experience in clinical operations, having held various roles in multiple organizations over the past decade.
Current Role at MAIA Biotechnology, Inc.
Paul Watkins serves as the Director of Clinical Operations at MAIA Biotechnology, Inc. He has held this position since 2022. In this role, he oversees clinical operations, ensuring that clinical trials are conducted efficiently and in compliance with regulatory standards. His leadership contributes to the advancement of innovative therapies within the organization.
Previous Experience at Atara Biotherapeutics
Before joining MAIA Biotechnology, Paul Watkins worked at Atara Biotherapeutics. He served as a Clinical Trial Specialist from 2016 to 2018, followed by a role as a Senior Clinical Trial Specialist for 9 months in 2018. His responsibilities included managing clinical trial processes and supporting the development of therapeutic products.
Experience at Plexxikon Inc.
Paul Watkins was employed at Plexxikon Inc. from 2018 to 2022. He initially worked as a Clinical Program Manager for two years before advancing to the role of Clinical Program Manager 2, where he continued for an additional two years. His work focused on overseeing clinical programs and ensuring successful trial execution.
Background in Clinical Research
Paul Watkins has a solid background in clinical research, having worked at UCSF Medical Center as a Lead Clinical Research Coordinator/Protocol Project Manager from 2013 to 2015. He also served as a Clinical Research Coordinator at the same institution from 2012 to 2013. His experience in these roles involved coordinating clinical trials and managing research protocols.
Educational Qualifications
Paul Watkins earned a Bachelor of Science (B.Sc.) degree in Biology from California Polytechnic State University-San Luis Obispo. He studied there from 2005 to 2011, which provided him with a strong foundation in the biological sciences, contributing to his career in clinical operations and research.